A new research paper titled “A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850” has been published in Oncotarget.
This article was originally published on MedicalXpress.com
Riluzole and sorafenib in patients with advanced solid tumors: A phase I trial
You may also be interested in:
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
The Latest
Exploring Attachment Styles and How They Affect Adult Relationships
Do you want to know more about attachment types and adult relationships? If so, you’ve come to the right place! In this blog, we’ll examine how different attachment styles impact our relationships and how understanding […]
The Latest
Why stress-related illness is so hard to diagnose, and how a patient-centred playful approach can help
For at least three decades, researchers have gathered evidence that chronic stress puts pressure on the body to constantly adjust itself to restore physiological stability. This process is known as allostatic load and it creates a cascade […]
Read More:
-
According to the U.S. Surgeon General, women should not drink alcoholic beverages during pregnancy because of the risk of birth defects in their unborn child. [...]
-
New technologies that can capture subtle changes in a patient’s voice may help physicians diagnose cognitive impairment and Alzheimer’s disease before symptoms begin to show, [...]
-
The COVID-19 pandemic led to increased weekday screentime for school-aged children says a new study involving the University of Ottawa published in JAMA Pediatrics.This article [...]
